Vision & Mission


We drive cutting-edge innovation in regenerative medicine using direct cell reprogramming to generate autologous blood products that can revolutionize the treatment of patients with immune and blood-forming diseases.


We aim to serve patients by translating scientific discoveries into products for blood regeneration. Our mission is to improve patients’ health by increasing the therapeutic efficacy of currently performed treatments for blood-based diseases. At the same time we aim to reduce the incidence of adverse side effects that represent a huge economic burden for healthcare systems.